NCT07629401
Pre-approval Expanded Access of Retatrutide (LY3437943)
Pre-approval Expanded Access of Retatrutide (LY3437943)
AvailableVerified
Trial registry record
What this means
The registry describes the study design and status. This label does not mean results have been reported.
Figure / record sourceLast verified 23 Oct 2026
Registry record
Trial details
- Trial
- Pre-approval Expanded Access of Retatrutide (LY3437943)
- ClinicalTrials.gov ID
- NCT07629401
- Indication
- Obesity, Obesity-related Complications
- Phase
- Not reported
- Study type
- Expanded_access
- Sponsor
- Eli Lilly and Company
- Enrolment
- Not reported
- Status
- Available
- Interventions
- Drug: Retatrutide
- Comparator
- Not reported
- Eligible ages
- 18 Years – No maximum
- Locations
- Not reported
- Study start
- Not reported
- Primary completion
- Not reported
- Study completion
- Not reported
Verification
- Last verified
- 23 Oct 2026
- Source
- ClinicalTrials.gov
- Registry last updated
- 6 Aug 2026